: President The Stock Exchange of Thailand Oishi Group Public Company Limited and its subsidiaries are pleased to submit Management Discussions and Analysis for the three-month and nine-month periods and
นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” August 14, 2020 Subject: Clarification on the cause of changes in operating results. To: Director and Manager The Stock Exchange
-1- AIT (VP-SEC) 012E/2021 May 6, 2021 Subject: Management's Discussion and Analysis of Operating Results for Q1-2021 To: The President of the Stock Exchange of Thailand Summary of Operations Q1–2021
Microsoft Word - 2020-Q1_MDA_Eng_R0.docx No. CAZ 010-2020 11 May 2020 Subject: Management Discussion and Analysis for the 1st Quarter ended 31 March 2020 Attention: The President, The Stock
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
(Translation) UAC.CS/015/2020 August 14, 2020 Subject: Explanation of the operating results for the second quarter period ended June 30, 2020 To: President The Stock Exchange of Thailand Attachment
1 RP-AC 003/2020 AUGUST 14, 2020 Subject: Clarification of the operating results for the second quarter of 2020 To: Directors and Managers of the Stock Exchange of Thailand Richy Place 2002 Public
29 October 2019 At: ACC/HO 023/19 Re: Management Discussion and Analysis for the Quarter of 3/2019 To: President The Stock Exchange of Thailand In the third quarter of 2019, there were concern on the
1 IDH-AC-000-อส6211/08.00 8 November 2019 Re: Management Discussion and Analysis Operating results for the three-month and nine-month period ended 30 September 2019 To: President The Stock Exchange
-1- AIT (VP-SEC) 012E/2021 May 6, 2021 Subject: Management's Discussion and Analysis of Operating Results for Q1-2021 To: The President of the Stock Exchange of Thailand Summary of Operations Q1–2021